Apollo Endosurgery Inc EV/EBIT
What is the EV/EBIT of Apollo Endosurgery Inc?
The EV/EBIT of Apollo Endosurgery Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Apollo Endosurgery Inc
What does Apollo Endosurgery Inc do?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Companies with ev/ebit similar to Apollo Endosurgery Inc
- Enochian Biosciences has EV/EBIT of N/A
- Enochian Biosciences has EV/EBIT of N/A
- Enochian Biosciences has EV/EBIT of N/A
- Enochian Biosciences has EV/EBIT of N/A
- Ocean Power Technologies has EV/EBIT of N/A
- Air France-KLM SA has EV/EBIT of N/A
- Apollo Endosurgery Inc has EV/EBIT of N/A
- Logica Ventures has EV/EBIT of N/A
- Spice Mobility has EV/EBIT of N/A
- eHealth Inc has EV/EBIT of N/A
- Epizyme Inc has EV/EBIT of N/A
- Nicox SA has EV/EBIT of N/A
- VOXX International Corp has EV/EBIT of N/A